Members Only

Events

12th International Congress of TDM & Clinical Toxicology
October 2 - 6, 2011
Stuttgart Germany
View photos from the Congress!

 

 

 

Login

Forgot Password

Our aims are:

  • Foster and promote education and research in therapeutic drug monitoring and clinical toxicology;

  • Improve the standards of practice and clinical interpretation of drug and toxic substance analyses and facilitate the delivery of interpretation through clinical pharmacokinetics and toxicokinetics for enhanced patient care;

  • Encourage cooperation with and among members of all professions concerned with TDM and clinical toxicology;

  • Encourage the effective application of therapeutic drug monitoring to optimize clinical drug use and maximize the clinical and economic benefits;

  • Encourage progress in clinical toxicology as a diagnostic tool and therapeutic aid for therapeutic drug overdoses, drug abuse, and exposure to environmental toxicants.


Application form (PDF) 

Definition of TDM

 

 

Journal

Therapeutic Drug Monitoring is the official journal of IATDMCT

IATDMCT members have free on-line access to the journal Therapeutic Drug Monitoring.

Instructions for authors

Latest News

  • Developing Countries Membership Survey
    Members in Developing Countries are asked to participate in a survey to identify/develop appropriate IATDMCT initiatives for supporting your local work in TDM/CT.
    If you wish to participate please contact the office for details.

     
  • Member-Get-A-Member Campaign Launched!
    January 1, 2012 - February 28, 2013
    PRIZE! The top "Recruiter" will receive a free registration* to the Salt Lake City Congress!

     
  • 2011-13 IATDMCT COUNCIL ELECTED
     Executive  
     President Dr. Pierre Marquet (France) 
     President-Elect  Dr. Pierre Wallemacq (Belgium) 
     Secretary Dr. Donald LeGatt (Canada) 
     Treasurer  Dr. Loralie Langman (USA) 
     Past President Dr. Alexander A. Vinks (USA) 
       
     Directors of
     Education    		 Mr. Paul Taylor (Australia) 
    Dr. Teun van Gelder (Netherlands) 
      Dr. Eberhard Wieland (Germany) 
       
     Councillors  Dr. Olof Beck (Sweden) 
      Dr. Frank Peters (Germany) 
      Dr. Katharina Rentsch (Switzerland) 
      Dr. Benedetta Sallustio (Australia) 
       

  • NEW!  Guidelines and application form to receive permission to hold your regional meeting under the auspices of IATDMCT can be found under menu item Meetings/Regional Meetings

  • NEW!  A limited number of regional meetings will receive support from IATDMCT in the form of provision and travel support for speakers.  Guidelines and the application form can be found under Meetings/Regional Meetings  
  • Members who are presenting at a conference should visit the IATDMCT Members Only section. There is a new page "IATDMCT Promotion" with a PowerPoint presentation, and other materials that can be taken to the conference to generate membership in IATDMCT.

  • Update of a review on new TDM assays, described in literature, based on dried blood spot methods.

  • New report from the Biomarker working group (BWG) within the Immunosuppressive Committee
  • Deuterated internal standards


      • Members pages are only accessible to members who have paid their dues.
      They contain the directory of members, monographs on digoxin, theophyllin, cyclosporin and tacrolimus, the newsletters and two articles on Busulfan monitoring by L. Langman and Pharmacogenomics for Clinical and Forensic Toxicology. An Adjunct for Interpretation of Drug Toxicity by Shi et al.

      P.O. Box 1570, 4 Cataraqui Street,
      Suite 310, Kingston, Ontario K7L 5C8 Canada,
      Tel: 613-531-8166 • Fax: 1-866-303-0626
      E-mail:       office@iatdmct.org

Powered By Dragonfly IT Ltd.